Skip to main content
. 2024 Apr 23;14(4):e081459. doi: 10.1136/bmjopen-2023-081459

Figure 2.

Figure 2

Standard Protocol Items: Recommendations for Interventional Trials figure. CTC NCI v5.0, National Cancer Institute Common Toxicity Criteria Version 5.0; DLQI, Dermatology Life Quality Index; HFS, hand–foot syndrome; HFS-14, Quality of Life Scale developed for patients suffering from HFS; PBM, photobiomodulation; Sham, placebo.